References

References

• Scottish Antimicrobial Prescribing Group, Penicillin Allergy Delabelling. https://www.sapg.scot/guidance-qi-tools/quality-improvement-tools/penicillin-allergy-de-labelling/ (accessed Aug 29 2024).

 

• The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected Antibiotic Allergy https://swab.nl/en/exec/file/download/192 (accessed Aug 29 2024)

 

• Standards of Care Committee of the British Society for Allergy and Clinical Immunology. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy 2015 doi:10.1111/cea.12468

 

• BSACI guideline for the set-up of penicillin allergy de-labelling services by non-allergists working in a hospital setting. Clin Exp Allergy. 2022. doi:10.1111/cea.14217

 

• Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial. Intensive Care Med 2024. org/10.1007/s00134-024-07448-x

 

• A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling ‘low risk’ patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systems. Journal of Infection 2024. org/10.1016/j.jinf.2024.01.015

 

• Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy. The PALACE Randomized Clinical Trial. JAMA Intern Med 2023. doi:10.1001/jamainternmed.2023.2986

 

• Reaction Risk to Direct Penicillin Challenges. A Systematic Review and Meta-Analysis. JAMA Intern Med 2024. doi:10.1001/jamainternmed.2024.4606